Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-096870
Filing Date
2020-08-19
Accepted
2020-08-19 16:03:27
Documents
1
Period of Report
2020-08-17

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 5895
  Complete submission text file 0001104659-20-096870.txt   7281
Mailing Address 565 EVERETT AVENUE PALO ALTO CA 94301
Business Address
AKKARAJU SRINIVAS (Reporting) CIK: 0001253170 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37813 | Film No.: 201117121

Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Issuer) CIK: 0001556263 (see all company filings)

EIN.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations